| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27241-231-01 | 27241-231 | HUMAN PRESCRIPTION DRUG | Carbamazepine | Carbamazepine | TABLET, EXTENDED RELEASE | ORAL | 20230324 | N/A | ANDA | ANDA216193 | Ajanta Pharma USA Inc. | CARBAMAZEPINE | 100 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-231-01) |
| 27241-232-01 | 27241-232 | HUMAN PRESCRIPTION DRUG | Carbamazepine | Carbamazepine | TABLET, EXTENDED RELEASE | ORAL | 20230324 | N/A | ANDA | ANDA216193 | Ajanta Pharma USA Inc. | CARBAMAZEPINE | 200 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-232-01) |
| 27241-233-01 | 27241-233 | HUMAN PRESCRIPTION DRUG | Carbamazepine | Carbamazepine | TABLET, EXTENDED RELEASE | ORAL | 20230324 | N/A | ANDA | ANDA216193 | Ajanta Pharma USA Inc. | CARBAMAZEPINE | 400 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-233-01) |